4Young JB, Gheorghiade M, Uretsky BF, et al. Superioritg of "Triple" drag therapy in heart failure: Lnsights from the PROVED and RADLANCE trials[ J]. J Am Coll Cardiol, 1998,32(4) : 686-692.
5No authors listed. Effectiveness of spironolactone added to an angiotensin- comverting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failare(the Randdomized Aldoctone Evaluation Study,RALES) [J]. Am J Cardiol, 1996,78(8):902-907.
6Ruffolo RR Jr, Feuerstein GZ. Neurohormonal activation, Oxygen gree radicals, and apoposis ,in the pathogenesis of congestive heart failure[ J]. J Cardiovasc Pharmacol, 1998,32[ Suppl 1 ] : S22-S30.
7Braunwald E, Bristow MR. Congestive heatr failure: fifty years of propress [J]. Circulation,2000,102[20 Suppl 4] : Ⅳ 14-23.
8Bristow MR. Beta-adrenergic receptor blocdacde in chronic heart failare[J]. Circulation, 2000,101 (5) : 558-569.
9Philbin EF, Rocco TA Jr, Lindenmath NW, et al. Systolic versus diastolic heart faihare in ommunity practice: clinical featyures, outcomes,and the use of angiotensin- convering enzyme inhibitors [ J ]. Am J Med,2000,109(8) :605-613.
1The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure[J]. N Engl J Med, 1997,336(8) :525-533.
2Kulbertus H. L'etude clinique dumois. L'etude RALES(randomized aldactone evaluation study ) [ J ]. Rev Med Lieee, 1999.54 (9) : 770-772.
3Cleland JGF, McGowan J, Clark A. The evidenee for β bl'ockers in heart failure[ J]. BMJ, 1999,318(7187) :824-825.
4Pitt B, Segal R, Martinez FA, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure( Evaluation of Losartan in the Elderly Study, ELITE) [ J ]. Lancet, 1997,349 (9054) : 747-752.
5Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopfil on mortality in patients with symptomatic heart failure:randomized trial-the losartan heart failure survial study ELITE Ⅱ[J]. Lancet,2000,355(9215) : 1582-1587.
6Cohn JN, Tognoni G, Glazer R, et al. Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators[ J]. Eur J Heart Fail,2000,2(4) :439-446.
7Dilenarda A,De Maria R,Gavazzi A, et al. Long-term survival effect of motoprolol in dilated cardiomyopathy. The SPIC (Italian Muhicentre Cardiomyopathy Study)Group [J]. Heart, 1998,79(4) :337-344.
8CIBIS-Ⅱ Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study Ⅱ( CIBIS-Ⅱ ) : a randomized trial [ J ]. Lancet, 1999,353(9146) :9-13.
9Hjalmarson A, Goldstein S, Fagerberg B, et al. Effect of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) [ J ]. Lancet, 1999,353(9169) :2001-2007.
10Parcker M, Coats AJ, Fowler MB, et al. The Effect of carvedilol on survival in severe chronic heart failure [ J]. N Engl J Med, 2001,344 (22) :1651-1658.
